rs34934281
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_001372106.1(DNAH10):c.5525C>T(p.Thr1842Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.106 in 1,613,898 control chromosomes in the GnomAD database, including 10,189 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001372106.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAH10 | NM_001372106.1 | c.5525C>T | p.Thr1842Met | missense_variant | 31/79 | ENST00000673944.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAH10 | ENST00000673944.1 | c.5525C>T | p.Thr1842Met | missense_variant | 31/79 | NM_001372106.1 | P1 | ||
DNAH10 | ENST00000409039.8 | c.5354C>T | p.Thr1785Met | missense_variant | 30/78 | 5 | |||
DNAH10 | ENST00000638045.1 | c.5171C>T | p.Thr1724Met | missense_variant | 30/78 | 5 | |||
DNAH10 | ENST00000497783.3 | c.713C>T | p.Thr238Met | missense_variant, NMD_transcript_variant | 4/21 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0823 AC: 12510AN: 152090Hom.: 681 Cov.: 32
GnomAD3 exomes AF: 0.0866 AC: 21594AN: 249236Hom.: 1154 AF XY: 0.0891 AC XY: 12054AN XY: 135212
GnomAD4 exome AF: 0.109 AC: 159130AN: 1461690Hom.: 9507 Cov.: 33 AF XY: 0.108 AC XY: 78864AN XY: 727126
GnomAD4 genome AF: 0.0822 AC: 12513AN: 152208Hom.: 682 Cov.: 32 AF XY: 0.0789 AC XY: 5869AN XY: 74408
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at